Company profile

Ticker
DNLI
Exchange
CEO
Ryan J. Watts
Employees
Incorporated in
Location
Fiscal year end
SEC CIK

DNLI stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

6 Nov 19
19 Feb 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 13.6M 4.2M 4.21M 125.68M
Net income -46.26M -58.34M -38.99M 77.53M
Diluted EPS -0.48 -0.61 -0.41 0.79
Net profit margin -340% -1390% -927% 61.69%
Operating income -50.16M -62.76M -42.51M 74.72M
Net change in cash 19.74M 23.28M -37.46M 33.47M
Cash on hand 82.67M 62.94M 39.66M 77.12M
Annual (USD) Dec 18 Dec 17 Dec 16
Revenue 129.16M NaN NaN
Net income -36.24M -88.19M -86.65M
Diluted EPS -0.39 -5.89 -13.49
Net profit margin -28.06% NaN% NaN%
Operating income -46.37M -90.14M -87.43M
Net change in cash -141.25M 178.52M
Cash on hand 77.12M 218.38M 39.85M

Financial data from company earnings reports

73.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 116 113 +2.7%
Opened positions 17 23 -26.1%
Closed positions 14 23 -39.1%
Increased positions 37 41 -9.8%
Reduced positions 23 23
13F shares
Current Prev Q Change
Total value 11.03B 1.47B +650.4%
Total shares 70.67M 70.81M -0.2%
Total puts 98.36K 15.8K +522.6%
Total calls 55.42K 50.6K +9.5%
Total put/call ratio 1.8 0.3 +468.5%
Largest owners
Shares Value Change
Crestline Management 19.46M $298.17M 0.0%
Flagship Pioneering 8.01M $122.65M 0.0%
Baillie Gifford & Co 7.36M $112.81M -0.6%
Vanguard 6.1M $93.41M +4.9%
BLK BlackRock 5.25M $80.38M +1.8%
FMR 4.91M $75.22M -2.7%
Temasek 4.41M $67.57M 0.0%
STT State Street 1.59M $24.39M -19.8%
Lord, Abbett & Co. 1.17M $17.92M -33.0%
Bamco 984.66K $15.09M 0.0%
Largest transactions
Shares Bought/sold Change
Lord, Abbett & Co. 1.17M -576.04K -33.0%
STT State Street 1.59M -393.93K -19.8%
Vanguard 6.1M +286.13K +4.9%
Casdin Capital 650K +250K +62.5%
Dimensional Fund Advisors 398.32K +193.78K +94.7%
FMR 4.91M -137.62K -2.7%
Balyasny Asset Management 0 -120.4K EXIT
BK Bank Of New York Mellon 338.92K +111.9K +49.3%
Citadel Advisors 88.41K -106.47K -54.6%
FHI Federated Hermes 0 -103.76K EXIT

Financial report summary

?
Competition
EisaiMallinckrodtBiogenAstraZenecaRocheShireCytokineticsSanofiAbbVieProthena
Risks
  • Risks Related to Our Business, Financial Condition and Capital Requirements
  • Risks Related to the Discovery, Development and Commercialization of Our Product Candidates
  • Risks Related to Regulatory Approval and Other Legal Compliance Matters
  • Risks Related to Our Reliance on Third Parties
Management Discussion
  • *  Percentage is not meaningful.
  • *  Percentage is not meaningful.
  • Collaboration Revenue. Collaboration revenue was $13.6 million and $22.0 million for the three and nine months ended September 30, 2019, respectively, and $1.2 million and $3.5 million for the three and nine months ended September 30, 2018, respectively. 
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: biomarker, clarification, Japan, NaN, Pronouncement, slightly, website
Removed: assured, confirmed